TranslationBlocker Human FoxP3 siRNA – DISCONTINUED

$ 248.00$ 368.00

Human FoxP3 siRNA Translation Blocker™ Duplex

SKU: QX48-2nmol Categories: , Tag:
 PDF Datasheet

DISCONTINUED: Human FoxP3 TranslationBlocker™ siRNA Duplex Product Attributes

Blocks transcription and translation of FoxP3 from: Human.
May also react with FoxP3 based upon sequence homology and clone specific publications.
Type of RNAi: siRNA.
siRNA target sequence: NM_001114377.
Samples and cell lines tested: HCT116-p53wt Human Carcinoma Cells from Colon and MCF7 Human Adenocarcinoma Cells from Breast Cancer.
Buffer and Stabilizer: Lyophilized. See datasheet for resuspension instructions and buffer information.
Concentration of Anti-Human FoxP3: Lyophilized
SiRNA Purification Method:RPC/HPLC
Storage Conditions: Store Lyophilized siRNA duplex at 4C. Reconsituted product may be stored at -20C for up to 1 month.

FoxP3 Knockdown Protocol:

    1. Starting with cultured cells in growth media seed plates with cells and incubated at 37°C. For instance, seed 12 well plates with 5×104 cells in growth media and incubate at 37°C overnight before starting transfections. Transfection reagents may specify the desired level of confluence to look for prior to starting transfections.
    2. Prepare transfection reagent in serum-free growth medium such as Opti-MEM-I. Allow to come to room temperature. Lipofectamine RNAiMAX was used to generate the above data in accordance with manufacturer’s instructions.</ li>
    3. Dilute siRNA to working concentration in serum-free growth media. For Lipofectamine RNAiMAX or similar transfections into 12 well plates, we recommend starting siRNA dose optimization at approximately 100 pmol siRNA duplex.Optimal dilution should be experimentally determined.
    4. Combine diluted siRNA and transfection reagent. Ratio of transfection reagent to siRNA should be optimized. Equivalent volumes of prepared Lipofectamine RNAiMAX or other transfection reagent and diluted siRNA should be combined and incubated at room temperature for 20 minutes with gentle mixing.
    5. Add prepared siRNA solution to cells. For 12 well plates this will entail adding the solution to cells in approximately 1.1 ml serum-free medium. Optionally, FITC labeled control siRNA (Product Number QC-1F) or positive control siRNA (Beta-Actin; Product Number QC-2) may be used to assess transfection efficiency.
    6. Incubate for several hours in serum free media. Generally, a 4 hour initial transfection incubation is recommended.
    7. Add serum containing media to culture without a media change if longer incubation times are required. Generally 1-2 fold of the original volume of siRNA containing serum-free media is added to restore nutrient levels in media. Alternatively, the media may be directly supplemented with serum such as 10% FBS.
    8. Incubate and assay several hours after transfection. Optimal knockdown time should also be experimentally determined. Optionally, a second transfection can be performed 24 hours after the first transfection to enhance knockdown. FoxP3 knockdown at the protein level was measured at 24 hours post transfection via Western Blot.

FoxP3 General Information

Gene Name: FoxP3
Entrez Gene ID: 50943
NCBI Ref Seq Accession Number: NP_001107849
Uniprot ID:
FoxP3 Molecular Weight:
Alternate Names: Forkhead Box P3, Scurfin, IPEX

Limitations and Warranty

This product is for Research Use Only. This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.



Product Type



There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

TranslationBlocker Human FoxP3 siRNA - DISCONTINUED